APA (7th ed.) Citation

M, S., IM, A., R, T., & AR, F. (2026). Bridging Therapeutics and Nanotechnology in Dry Eye Disease: A Review of Risk Factors, Drug Delivery Barriers, and Recent and Future Endeavors for Disease Management. AAPS PharmSciTech, 27(4), . https://doi.org/10.1208/s12249-026-03442-2

Chicago Style (17th ed.) Citation

M, Salama, Adel IM, Tag R, and Fares AR. "Bridging Therapeutics and Nanotechnology in Dry Eye Disease: A Review of Risk Factors, Drug Delivery Barriers, and Recent and Future Endeavors for Disease Management." AAPS PharmSciTech 27, no. 4 (2026). https://doi.org/10.1208/s12249-026-03442-2.

MLA (9th ed.) Citation

M, Salama, et al. "Bridging Therapeutics and Nanotechnology in Dry Eye Disease: A Review of Risk Factors, Drug Delivery Barriers, and Recent and Future Endeavors for Disease Management." AAPS PharmSciTech, vol. 27, no. 4, 2026, https://doi.org/10.1208/s12249-026-03442-2.